FDA Approved: PREMARIN VAGINAL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

FDA approved a supplemental application for PREMARIN VAGINAL (conjugated estrogens) to update its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrophic Vaginitis
• Genitourinary Syndrome of Menopause

Drugs mentioned

• PREMARIN VAGINAL (Conjugated estrogens)

Snippet

SUPPL AP for PREMARIN VAGINAL (CONJUGATED ESTROGENS)